The ARAMIS Trial: DAPT vs Alteplase in Minor Nondisabling Acute Ischemic Stroke
Background: Current stroke guidelines recommend IV alteplase for patients with acute ischemic stroke presenting within 4.5hrs of symptom onset based on the NINDS and ECASS III publications. Both NINDS and …